4.6 Article

Cost-effectiveness of the National Health Service abdominal aortic aneurysm screening programme in England

期刊

BRITISH JOURNAL OF SURGERY
卷 101, 期 8, 页码 976-982

出版社

WILEY
DOI: 10.1002/bjs.9528

关键词

-

类别

资金

  1. UK National Institute for Health Research Health Technology Assessment Programme [08/30/02]
  2. British Heart Foundation [RG/08/014/24067] Funding Source: researchfish
  3. Medical Research Council [MR/L003120/1] Funding Source: researchfish
  4. National Institute for Health Research [NF-SI-0512-10165, 08/30/02] Funding Source: researchfish
  5. MRC [MR/L003120/1] Funding Source: UKRI

向作者/读者索取更多资源

Background: Implementation of the National Health Service abdominal aortic aneurysm (AAA) screening programme (NAAASP) for men aged 65 years began in England in 2009. An important element of the evidence base supporting its introduction was the economic modelling of the long-term cost-effectiveness of screening, which was based mainly on 4-year follow-up data from the Multicentre Aneurysm Screening Study (MASS) randomized trial. Concern has been expressed about whether this conclusion of cost-effectiveness still holds, given the early performance parameters, particularly the lower prevalence of AAA observed in NAAASP. Methods: The existing published model was adjusted and updated to reflect the current best evidence. It was recalibrated to mirror the 10-year follow-up data from MASS; the main cost parameters were re-estimated to reflect current practice; and more robust estimates of AAA growth and rupture rates from recent meta-analyses were incorporated, as were key parameters as observed in NAAASP (attendance rates, AAA prevalence and size distributions). Results: The revised and updated model produced estimates of the long-term incremental cost-effectiveness of 5758 pound (95 per cent confidence interval 4285 pound to 7410) pound per life-year gained, or 7370 pound (5467 pound to 9443) pound per quality-adjusted life-year (QALY) gained. Conclusion: Although the updated parameters, particularly the increased costs and lower AAA prevalence, have increased the cost per QALY, the latest modelling provides evidence that AAA screening as now being implemented in England is still highly cost-effective.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据